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ABSTRACT
Objectives To determine the role of adherence and its
signiﬁcance in the relationship between self-efﬁcacy and
self-management of diabetic patients undergoing
coronary artery bypass graft (CABG) in Taiwan.
Design Descriptive and correlational survey design.
Setting Three outpatient clinics in Taiwan.
Participants Patients diagnosed with diabetes
undergoing CABG at least 6 months before the study,
18 years of age or older, able to communicate verbally
without any psychiatric problems, and with a life
expectancy longer than 1 year.
Main outcome measures Self-management
assessment (self-efﬁcacy for managing disease and
adherence to guidelines and medication measured on a
scale of 0–8), the higher aspects of self-management
(keeping appointments, taking medication properly and
keeping follow-up appointments) and the lower aspects
of self-management (inability to share decisions with
primary physician, inability to take correct actions when
symptoms worsen and inability to adapt habits to
improve health).
Results The mean score obtained for self-management
among the 166 participants was 6.48, with 57 (34.3%)
of them showing non-adherent behaviour. Self-efﬁcacy
accounts for 38% (R2=0.380, F(1,103)=63.124,
p < 0.001), and 54% of good self-management was
explained by self-efﬁcacy and adherence in managing
disease (R2=0.540, F(2,102)=56.937, p<0.001).
Adherence accounts for 16% of better self-management,
age and education combined account for 4.9%
(R2=0.589, F(6.98)=23.399, p<0.001), and lifestyle
items account for 5.2% (R2=0.641, F(14,90)=11.457,
p<0.001). Disease-related variables contribute 3.4%
(R2=0.674, F(17,87)=10.599, p<0.001). Thus self-
efﬁcacy, adherence, age, education, primary care provider
and systolic pressure are considered signiﬁcant
predictors of self-management. With the exception of
adherence, none of the variables had a statistically
signiﬁcant mediating effect.
Conclusions The results conﬁrm strong relationships
between self-efﬁcacy, adherence and self-management,
with adherence having a signiﬁcant mediating effect in
post-CABG patients with diabetes in Taiwan.
INTRODUCTION
Cardiovascular diseases are the leading cause of
death worldwide, accounting for 29% of all deaths
according to WHO.1 Speciﬁcally, 17.3 million
people die annually from cardiovascular diseases,
with 7.2 million from coronary artery disease
(CAD). In Taiwan, CAD accounts for more than
10 000 deaths per year. Coronary artery bypass
graft (CABG) is an effective way to treat CAD;
thus the number of CABGs has increased over the
years.2 3
Diabetes mellitus is a signiﬁcant predictor of
CAD,4 and approximately one-third of CABG
patients are diagnosed with diabetes.5 Patients
with diabetes undergoing CABG have slower recov-
ery than the general population because of more
complications after surgery and cardiac adverse
events, resulting in a higher mortality.4 6 7–11
Type 2 diabetes mellitus is a metabolic as well
as a vascular disease. More frequent restenosis and
increased atherosclerosis progression after revascu-
larisation occur in diabetic patients undergoing
CABG compared with non-diabetic patients. Thus,
to maintain health, diabetic patients must adhere
to the medication regimen and follow-up visits.
Hyperglycaemia alone signiﬁcantly increases
cardiac events; therefore glucose control (maintain-
ing optimal glycated haemoglobin (HbA1C)) is
related to positive post-CABG outcomes.8 12 13
About 70% of diabetic patients do not believe
they are at risk of cardiac events.14 Cramer et al
reviewed studies of patient compliance/persistence
with cardiovascular or anti-diabetes medication
published since 2000.12 They found that patients
not adhering to such medication is a signiﬁcant
problem; ∼30% of patients do not take their medi-
cation as speciﬁed and only 59% do take it at least
80% of the time. Although compliance is deﬁned
interchangeably with adherence in various
studies,15 16 adherence is used more commonly.17
Adherence means that patients actively participate
in their disease management and do what it is
required of them.17 18
In Taiwan, diabetic patients do not manage
their disease appropriately; only 14% of elderly
diabetic patients have HbA1C values within the
optimal range of <6.5.19 Therefore assessing
post-CABG diabetic patients on medication and
improving their adherence to treatment and medi-
cation is very important.
Adherence promotes good self-management,
which is the key to health improvement, achieved
by guiding patients to take an active role in their
treatment and take responsibility for day-to-day
disease management.20 21 Good self-management
has the potential to cut healthcare costs through
the prevention of long-term complications and
reduction of the physical and psychological burden
of the disease.15 22 23 Self-management can occur
over the entire continuum of care, which spans
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from hospital to home care. Traditionally, patients received
medical care from medical personnel; however, self-
management has increased in popularity, as it reduces the
burden of chronically ill patients as well as reducing the burden
of caregivers and the healthcare system.24
Self-management can be inﬂuenced by the patient’s beliefs
about its ease or difﬁculty.23 This belief is termed self-efﬁcacy,
which focuses on individuals’ convictions that they have
control over their behaviour through their motivation to
achieve desired outcomes25 26 Self-efﬁcacy was developed on
the basis of four sources: past successful experiences, empath-
etic experiences from social models, social persuasion, and
physical and mental status.25 27 Because self-efﬁcacy can lead
to behavioural changes, it plays an important role in the self-
management of chronic disease.21 28 According to Bandura,27
self-efﬁcacy provides conﬁdence to achieve the behavioural
change needed to respond to challenges. Self-efﬁcacy is posi-
tively related to health behaviour and to change in health
status.29 Thus assessing and enhancing self-efﬁcacy are
important for patients who need to engage in better self-
management.
The important factors that affect self-management have
been identiﬁed in a theory of diabetic self-care management
developed by Sousa and Zauszniewski in 2005.31 Their model
was derived from Orem’s self-care (1995) and Bandura’s self-
efﬁcacy (1997) theories,26 32 which reveal that inﬂuencing
factors are part of constructs that include both internal (per-
sonal) and external (environmental) factors related to the self-
care process. The important constructs are Bandura’s personal
and social systems and Orem’s basic conditioning factors.
Orem proposed that the basic conditioning factors are age,
gender, developmental state, health status, sociocultural orien-
tation, healthcare system, family system, pattern of living, the
environment, and resource availability and adequacy.32 Based
on the diabetic self-care management model,31 adherence and
self-efﬁcacy are the internal factors in this study.
In summary, self-management is critically important for pro-
moting better outcomes for post-CABG patients with diabetes.
Adherence and self-efﬁcacy correlate with self-management.
However, the contribution of adherence, self-efﬁcacy, demo-
graphic factors, lifestyle and disease characteristics to self-
management is not known. Therefore the primary objective of
this research is to determine the predictors of self-management in
post-CABG patients with diabetes. The aims are to (a) examine
the contribution of adherence, self-efﬁcacy, demographic vari-
ables, lifestyle and disease characteristics to self-management,
(b) determine the reasons for patient non-adherence, and
(c) examine the mediating effect of adherence and other inﬂuen-
cing variables on the relationship between self-efﬁcacy and
self-management.
METHODS
Design overview
The study used a cross-sectional, descriptive and correlational
survey design. Ethics approval to conduct the research was
obtained from the appropriate institutional review boards, and
all participants gave their informed consent. Data were gath-
ered by four self-administered questionnaires, described below,
in three outpatient clinics while patients were waiting for
a doctor ’s appointment or after they had been seen by the
doctor before leaving the clinic. The research assistant, who
was institutional review board certiﬁed and trained in assisting
patients to ﬁll out the questionnaires, was also responsible for
collecting data from all the clinics.
Participants
The study sample consisted of 166 diabetic patients who
underwent CABG in three outpatient clinics and were seen for
follow-up between August 2010 and March 2011. The inclusion
criteria for the study were (a) diagnosed with diabetes,
(b) underwent CABG at least 6 months before the study,
(c) 18 years of age or older, and (d) able to communicate ver-
bally. Patients were excluded from the study on the basis of the
following criteria: (a) psychiatric problems conﬁrmed by a
psychiatrist or (b) a comorbid condition such as malignancy or
a major trauma that would limit life expectancy to less than
1 year.
For estimating the sample size, G*Power V.3.1 was used
(Department of Criminology, University of Melbourne, Parkville,
Victoria, Australia). The signiﬁcance level was set at α=0.05, the
statistical power at (1−β)=0.80, and effect size at 0.25. Effect size
was determined as described in the study by Loring et al study,24
which examined health status and healthcare utilisation of a
chronic disease self-management programme.
Measurements
Demographic questionnaire
The questionnaire collected demographic, lifestyle and disease
information. Demographic data included age, gender, marital
status, education, religion and socioeconomic status. Lifestyle
information included alcohol use, tobacco use, primary care
provider, employee status and exercise habits. Disease-related
characteristics included time since diagnosis of diabetes, adverse
effects of medication, coexisting diseases, laboratory results,
and related clinical data.
Partners in Health Scale (PHS)
General self-management was assessed using the PHS, which
addresses generic self-management for various chronic illnesses.
The PHS consists of 11 items that address different aspects of
disease self-care, including obtaining disease-related informa-
tion, sharing in decisions, taking medication, understanding of
and ability to monitor symptoms and respond to symptom
changes, and making and keeping appointments. The scale uses
a Likert-type scale with responses ranging from 0 (very good)
to 8 (poor). Total scores can range from 0 (very good self-
management) to 88 (poor self-management). The scale has
been used in various studies across different countries.24 33–35
The reliability of the scale has been determined in several
chronically ill populations, with a Cronbach’s α of 0.92.23
Self-Efﬁcacy for Managing Chronic Disease Scale (SES)
Conﬁdence in one’s ability to manage chronic illness was
assessed using a modiﬁed version of the SES.23 The SES consists
of 33 items divided into 10 subscales with conﬁdence levels for
doing a certain activity: (a) exercising regularly; (b) obtaining
information about disease; (c) obtaining help from the commu-
nity, family and friends; (d) communicating with physicians;
(e) managing the disease in general; (f ) doing chores; (g)
engaging in social/recreational activities; (h) managing symp-
toms; (i) managing shortness of breath; and ( j) controlling/
managing depression.
The scale uses a Likert-type scale, and responses range from
1 (not at all conﬁdent) to 10 (totally conﬁdent). Responses
were summed, and a mean score, ranging from 1 (low self-
efﬁcacy) to 10 (high self-efﬁcacy), was calculated. The scale has
been tested with several diverse chronically ill groups.23 35 36
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The reliability of the scale (Cronbach’s α=0.89) has been
determined.24
Cardiovascular Diabetic Adherence Scale (CDAS)
Patient adherence was assessed using the CDAS, which was
developed by an expert panel composed of one nursing faculty
member, one cardiac surgeon and four registered nurses with
over 10 years of experience. The CDAS consists of nine items
that focus on diabetic and post-CABG adherence. The CDAS
uses a Likert-type scale, and responses range from 1 (not at all
compliant) to 5 (totally compliant). The total score was 45, and
a score bellow 37 was considered non-adherent. Content validity
was conﬁrmed by an expert panel, who determined a 0.93
content validity index. The Cronbach’s α was 0.627 for internal
consistency. The conﬁrmatory factor analysis showed goodness-
of-ﬁt index (GFI)=0.95, comparative ﬁt index (CFI)=0.95, root
mean square error of approximation (RMSEA)=0.06 and stan-
dardised root mean square residual (SRMR)=0.064, meaning an
acceptable ﬁt.
Statistical analysis
SPSS V.17.0 software was used for data analysis. Descriptive
statistics were performed to analyse demographic data.
Hierarchical regression analysis was used, with self-management
chosen as the dependent variable, and self-efﬁcacy, adherence
level and other patient characteristics as independent variables.
A multiple mediation script was used to present the mediating
effect on self-management. Lastly, conﬁrmatory factor analysis
and coefﬁcient α were used to ensure the psychometric proper-
ties of the instrument. The level of statistical signiﬁcance for
analyses was set at p<0.05.
RESULTS
Psychometric properties of translating instruments
Two of the four questionnaires, the PHS for measuring self-
management and SES for measuring self-efﬁcacy, were originally
in English. They were translated into Chinese by a health profes-
sional who is proﬁcient in English but whose primary language
is Chinese. In addition, a bilingual expert with a healthcare
background was asked to examine whether any of the transla-
tions were inadequate and to correct them. The instrument was
translated back into English by an independent translator, who
is a native speaker without a medical background. This was
carried out to ensure the validity of the Chinese translation.
Conﬁrmatory factor analysis was used to assess whether
the factor structure of the PHS (GFI=0.94; CFI=0.99;
RMSER=0.068; standardised RMR=0.043) and SES (GFI=0.99;
CFI=0.96; RMSER=0.13; standardised RMR=0.061) is the
same in English as it is in Chinese. Lastly, Cronbach’s α was
0.891 for the Chinese version of the PHS and 0.973 for the
Chinese version of SES in the present study.
Demographics
As presented in table 1, the mean age of the participants was
67.5, and 80.1% were male. With regard to lifestyle, 25.9% of the
participants never used tobacco, and 28% had never used alcohol.
Fewer than half (40.4%) of the participants exercised regularly.
Disease characteristics
As seen in table 2, 73.5% of participants had hypertension, and
11.4% had renal disease. One hundred patients (60.2%) had
postoperative discomfort and diabetic complications. Notably,
the majority of the patients (88.5%) took four to 10 different
kinds of pills.
Self-management
The score of each item in this scale ranges from 0 to 8, the
lowest indicating the best self-management. The better self-
management aspects were: keeping appointments (1.07±1.76);
taking prescribed medicine (1.20±1.98); setting follow-up
appointments (1.42±2.01). The lower aspects of self-
management were: patients being able to share decisions with
their primary physician (3.36±2.44); taking correct actions
when symptoms worsen (3.08±2.11); adapting habits to
improve health (3.01±2.11).
Self-efﬁcacy for managing disease
The mean score obtained was 6.48. The top three items for
which the participants had the highest conﬁdence were man-
aging symptoms, engaging in social and recreational activities,
and obtaining help from the community, family and friends.
The top three items for which participants had the least conﬁ-
dence were exercising regularly, managing shortness of breath,
and controlling/managing depression.
Adherence
The top three items that patients adhered to most closely were
abstinence from tobacco and alcohol and keeping scheduled
appointments. The top three items that patients adhered to
Table 1 Demographics of study participants
Variable Number Percentage
Gender
Male 133 80.1
Female 33 19.9
Age (mean±SD 68±9.5)
<50 years 8 4.8
51–60 years 38 22.9
61–70 years 57 34.3
>70 years 66 37.9
Education
Non-literate 22
Elementary 50 43.4
High school 58 34.9
Associate degree or above 36 21.7
Marital status
Married 146 87.9
Unmarried 4 2.5
Separated/divorce 16 9.6
Employee status
Yes 27 16.3
No 139 83.7
Primary caregiver
Self 85 51.2
Family/others 81 48.8
Exercise
Never/seldom 54 32.5
Not regular 45 27.1
Regularly 67 40.4
Tobacco use
Never 43 25.9
Quit 113 68.1
Regular 10 6
Alcohol use
Never 47 28.3
Quit 108 65.1
Regular 11 6.6
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least were regular exercise, checking their blood sugar, and
diet. Of the 166 patients, 57 (34.3%) showed non-adherent
behaviour.
Reasons for non-adherence
As seen in table 3, the most common reasons for non-
adherence were forgetting to take medicine, difﬁculty in chan-
ging habits, lack of energy, and no help.
Predictors of self-management
Stepwise regression was ﬁrst used to predict the demographics,
lifestyle factors and disease characteristics that correlated with
self-management. Next, hierarchical regression was performed,
with self-management as the dependent variable to determine
the relationship with other variables. As presented in table 4,
ﬁve models were used. Joint mediation effect analysis was used
to determine the effect of adherence and other variables on the
relationship between self-efﬁcacy and self-management.
In model 1, self-efﬁcacy accounts for 38% (R2=0.380,
F(1,103)=63.124, p<0.001). In model 2, 54% of good self-
management was explained by self-efﬁcacy and adherence in
managing diseases (R2=0.540, F(2,102)=56.937, p<0.001).
In model 2, adherence accounts for 16% of better self-
management. As demonstrated in models 3 and 4, age and
education together account for only 4.9% (R2=0.589, F(6.98)
=23.399, p<0.001), and lifestyle items account for only 5.2%
(R2=0.641, F(14,90)=11.457, p<0.001). Model 5 revealed that
disease-related variables contribute only 3.4% (R2=0.674,
F(17,87)=10.599, p<0.001). Thus self-efﬁcacy, adherence, age,
education, primary care provider and systolic pressure are con-
sidered signiﬁcant predictors of self-management.
As presented in table 4 and ﬁgure 1, only adherence was stat-
istically signiﬁcant and had an 18.5% mediating effect on the
relationship between self-efﬁcacy and self-management (95%
CI=−0.0472 to −0.0115). Demographic items had an 8.3%
mediating effect (95% CI=−0.0255 to 0.0021), lifestyle items
had a 10.8% mediating effect (95% CI=−0.0297 to 0.0100),
and disease characteristics had a 3.2% (95% CI=−0.0546 to
0.0577) mediating effect. However, with the exception of
adherence, none of these variables had a statistically signiﬁcant
mediating effect.
DISCUSSION
The mean score for self-efﬁcacy in managing disease is 6.48,
similar to previous research.23 24 37 Pang et al conducted a cross-
sectional study to determine the factors that inﬂuence disease
management self-efﬁcacy in 44 individuals with a spinal cord
injury in Taiwan,37 obtaining a mean score of 6.5 out of 10.
Gallager et al25 and Lorig et al24 reported a similar level of self-
efﬁcacy in a chronic-disease population in the West.
The total score for self-management in our study was 25.08,
similar to a score of 23.93 obtained by Gallagher et al. In add-
ition, our study found self-efﬁcacy to be a strong predictor of
better self-management.25 Gallagher et al used a prospective
and descriptive design to examine levels of self-management in
300 patients with chronic illness, showing that patients with
low self-efﬁcacy, a poor sense of coherence, and older age tend
to have poor self-management.25 In addition, in a more recent
study, Zhong et al found that strong self-efﬁcacy was positively
associated with good self-management.28 Thus promoting self-
efﬁcacy can have a profound inﬂuence on self-management.
With regard to adherence, 34.4% of our participants were
non-adherent. This result is consistent with that of Cramer
et al, who found that 41% of their participants neglected
prescribed medication.12 Diet, control and exercise were non-
adherent items, also seen in previous research.38–40 In our
study, forgetting to take medicine was the most common
reason for non-adherence. Topinkova et al conducted a cross-
sectional comparative study in 3881 elderly people receiving
home-care services in 11 European countries. Non-adherence to
prescriptions was the most common issue among patients.41
Topinkova et al recommended simplifying the drug regimen as
Table 3 Reasons for non-adherence
Variable Number Percentage Ranking
Forgetting to take the medicine 103 62 1
Having difficulty changing habits 98 59 2
Lack of energy 98 59 2
Having no one to help 64 38.6 3
The symptoms were not worse 43 25.9 4
It’s bothersome to take medicine for a long time 30 18.1 5
The symptoms did not improve 24 14.5 6
Having the disease for a long time 24 14.5 6
The diseases that I have cannot be treated to
produce complete recovery
23 13.9 7
Too many medicines to take 15 9 8
Taking different medicines at different time
points was too complicated
14 8.4 9
Too busy to take medicine 12 7.2 10
It is too far from my home to the hospital 7 4.2 11
Adverse effect of the medicines 5 3 12
Table 2 Disease characteristics of the study participants
Variable Number Percentage
Comorbidities
Hypertension 122 73.5
Renal disease 19 11.4
Cerebrovascular accident/stroke 8 4.8
Liver diseases 7 4.2
Hyperlipidaemia 3 1.8
Other 32 16.6
Number if coexisting disease
Up to there 139 83.7
More than three 27 16.3
Diabetic complication
Yes 66 39.8
No 100 60.2
Number of medications
<3 6 3.6
4–7 93 56
8–10 54 32.5
11–14 8 4.8
>15 5 3
Time since diabetes diagnosed
<1 year 14 8.4
1–5 years 38 22.9
6–10 years 48 28.9
>10 years 66 39.8
Time since surgery
<1 year 46 27.7
1–5 years 70 42.1
6–10 years 30 18.1
>10 years 20 12.1
Body weight
Below average 16 9.6
Normal 106 63.9
Overweight 44 26.5
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much as possible for seniors undergoing polypharmacother-
apy.41 This is relevant to our study, as the majority of patients
take between four and 10 kinds of pills.
Our study found that adherence had a 10.8% mediating
effect on the relationship between self-efﬁcacy and self-
management. In relation to our ﬁndings, Zhong et al found
that adherence to medication was inﬂuenced by attitude
toward self-management.28 Furthermore, Costantini et al noted
that, when practitioners include the patients’ beliefs and
concerns in the treatment plan, treatment outcomes are
enhanced.20 Involvement of patients and their families in
making decisions for their care plan and assessment of patients’
self-management ability are crucial to the success of the treat-
ment plan.
Participants were recruited from three hospitals, all located in
Taipei, Taiwan. The characteristics of an urban sample might
be different from those of a rural sample. Larger samples
are recommended in future studies to better represent the
population being investigated. The adherence instrument was
used for the ﬁrst time in this study, only with this sample’s
speciﬁc population. The conﬁrmatory factor analysis showed a
good ﬁt of data to one concept. However, inputting patients’
opinions when the adherence instrument is developed and also
after the study is completed is recommended to increase reli-
ability. The self-efﬁcacy and self-management instruments
were translated from English, and a pilot test before use might
be needed to conﬁrm the psychometric properties. This paper
focused only on diabetic patients who underwent CABG, and
the difference in health needs and self-management between
diabetic and non-diabetic patients is not known.
CONCLUSIONS
The results conﬁrm strong relationships between self-efﬁcacy,
adherence and self-management in post-CABG patients
with diabetes in Taiwan. This ﬁnding should be valuable to
clinicians, and related strategies should be able to be developed
on its basis.
In addition, areas of weakness in self-efﬁcacy and reasons for
non-adherence were identiﬁed. Primary care providers can use
this information to help patients to maintain a healthier life-
style and to enhance adherence. In this study, eight patients
lived alone, requiring hospital-based home services and locating
Table 4 Determinants of self-management
Model Model 1 Model 2 Model 3 Model 4 Model 5
variable β t p Value β t p Value β t p Value β t p Value β t p Value
Self-efficacy −0.616 −7.945 <0.001 −0.518 −7.502 <0.001 −0.496 −7.385 <0.001 −0.413 −5.356 <0.001 −0.410 −5.387 <0.001
Adherence −0.412 −5.964 <0.001 −0.417 −6.231 <0.001 −0.408 −5.940 <0.001 −0.349 −4.888 <0.001
Demographics
Age −0.181 −2.719 0.008 −0.196 −2.906 0.005 −0.201 −2.783 0.003
Education −0.258 −2.304 0.023 −0.239 −2.111 0.038 −0.273 −2.447 0.015
Lifestyle
Primary care 0.184 2.468 0.015 0.147 2.166 0.045
Employee status −0.113 −1.514 0.134 −0.054 −1.291 0.467
Tobacco use −0.023 −0.295 0.769 −0.017 −0.120 0.826
Disease characteristics
Adverse 0.064 0.988 0.356
Coexisting disease 0.139 0.735 0.054
Systolic pressure 0.139 2.092 0.045
R2 0.380 0.540 0.589 0.641 0.674
F 63.124 59.937 23.399 11.457 10.599
p <0.001 <0.001 <0.001 <0.001 <0.001
ΔR2 0.380 0.160 0.049 0.052 0.034
ΔF 63.124 35.567 2.899 1.616 3.13
Mediation effects
Indirect value 18.5 8.3 10.8 3.2
95%CI −0.0472 to −0.0115 −0.0255 to 0.0021 −0.0297 to 0.0100 −0.0546 to 0.0577
Δp <0.001 <0.001 0.026 0.131 0.034
Figure 1 Mediating role of adherence
in relationship between self-efﬁcacy and
self-management. M, mediation effects
(%); R2, explanatory power.
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of community resources to help them meet healthcare needs.
Further, forgetting to take medicine was the most common
reason reported for non-adherence. The majority of the partici-
pants took between four and 10 different kinds of pills. Thus
we recommend that the primary physician consults with the
multidisciplinary team to review the list of medications. In
addition, involvement of family members or volunteers or the
use of a mobile phone alarm may help patients to take their
medicines at the proper times. The results of this study should
provide healthcare professionals with a better understanding of
the importance of enhancing self-efﬁcacy and adherence and
the use of patient demographics and disease characteristics to
promote better self-management.
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What is already known on this topic
▸ Self-efﬁcacy in managing disease is the main contributor to
better self-management revealed by previous studies in both
Asia and North America.
What this study adds
▸ In this study we found self-efﬁcacy to be a strong predictor
of better self-management, with adherence having a
signiﬁcant mediating effect on the relationship between
self-efﬁcacy and self-management.
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